Short-Term Outcomes of Complete Mesocolic Excision vs D2 Dissection in Patients Undergoing Laparoscopic Colectomy for Right Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Short-Term Outcomes of Complete Mesocolic Excision Versus D2 Dissection in Patients Undergoing Laparoscopic Colectomy for Right Colon Cancer (RELARC): A Randomised, Controlled, Phase 3, Superiority Trial
Lancet Oncol 2021 Feb 12;[EPub Ahead of Print], L Xu, X Su, Z He, C Zhang, J Lu, G Zhang, Y Sun, X Du, P Chi, Z Wang, M Zhong, A Wu, A Zhu, F Li, J Xu, L Kang, J Suo, H Deng, Y Ye, K Ding, T Xu, Z Zhang, M Zheng, Y XiaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.